ReviewCureus2023

Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor Therapy for the Primary and Secondary Prevention of Heart Failure in Patients With and Without Type 2 Diabetes Mellitus: A Systematic Review.

Maureen Wahinya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.